Clinical & Commercial Outcomes
Our partnerships
Working closely with our clinical partners ensures our work responds to community health needs.
Our commercial partners play an essential role in translating research into practice.
Research projects in collaboration with commercial partners include:
Living Cell Technologies -
Protecting Auditory Nerve Cells Using Neurotrophin Cells (NTCell™ )
Polyactiva Pty Ltd -
Therapeutic Drug Delivery using Nanotechnology
Real-world results
Our staff have a proven track record in translational research - research discoveries that translate to improved health and wellbeing in the community and to the development of Australia's high-tech industry. The profiles below are in in pdf format 
A/Prof Chris Williams
- inventor and innovator
Prof Hugh McDermott
- real solutions for hearing loss
Prof Peter Seligman
- cochlear implant pioneer
Prof Peter Blamey
- scientist & entreprenuer
Prof Rob Shepherd
- leader in medical bionics
Prof Mark Cook
- "benchtop to bedside" research
Prof Dexter Irivine
- understanding the hearing brain
A new approach to creating medical bionics devices
From restoring lost hearing to regulating heart rate - medical bionics devices perform vastly different roles in enhancing or replacing organs in the human body.
However, the technology and expertise required the creation of medical bionics devices can be used in multiple applications.
To maximise our capablitites we are developing a medical bionics platform technology. This involves collaborating with key clinical and engineering partners to enable the transferral of technological advances from one project to another.
We believe the platform technology approach is unique in this field and will play an important role in sustaining and growing the Institute and the development of medical bionics devices in Australia.